Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data

1 Jan 2020

Abstract excerpt

Bladder cancer (BLCA) is a common malignant cancer, and it is the most common genitourinary cancer in the world. The recurrence rate is the highest of all cancers, and the treatment of BLCA has only slightly improved over the past 30 years. Genetic and environmental factors play an important role in the development and progression of BLCA. However, the mechanism of cancer development remains to be proven....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32047816
DOI: 10.1155/2020/8283401

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO DataPMID 32047816Read ↗

Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics AnalysisSemantic proximity Read ↗

Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysisSemantic proximity Read ↗

Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental AssaysSemantic proximity Read ↗

Identification of hub genes associated with bladder cancer using bioinformatic analysesSemantic proximity Read ↗

Identification of differentially expressed genes, biological pathways and prognostic signature in bladder cancerSemantic proximity Read ↗

Identification of key candidate genes and biological pathways in bladder cancerSemantic proximity Read ↗

MYLK, CNN1, TAGLN and LMOD1 identified as potential prognostic biomarkers for bladder cancer using bioinformatics analysisSemantic proximity Read ↗

Molecular Landscape of Bladder Cancer: Key Genes, Transcription Factors, and Drug InteractionsSemantic proximity Read ↗

Three Prognostic Biomarkers Correlate With Immunotherapy Response in Bladder Urothelial CarcinomaSemantic proximity Read ↗

Identification and Prognostic Analysis of Hub Genes in Bladder CancerSemantic proximity Read ↗

CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysisSemantic proximity Read ↗

Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.